Heywood, Lauren
Conti, Janet
Touyz, Stephen
Madden, Sloan
Hay, Phillipa
Article History
Received: 2 September 2023
Accepted: 24 January 2024
First Online: 31 January 2024
Declarations
:
: Written informed consent and ethics approval were obtained at the time of the initial study, and for this embedded research by the HREC at the Western Sydney University (HR777332).
: Consent for publication of individual data was obtained at the point of initial study written informed consent and ethics approval.
: The authors LH and JC declare that they have no competing interests. Author PH has received sessional fees from the Therapeutic Guidelines publication and the Health Education and Training Institute (HETI, NSW), and royalties/honoraria from Hogrefe and Huber, McGraw Hill Education, Blackwell Scientific Publications, BioMed Central, and PLOS Medicine. She has prepared a report under contract for Takeda (formerly Shire) Pharmaceuticals regarding binge eating disorder (July 2017) and is a consultant to Takeda Pharmaceuticals. Author ST has chaired the Takeda Australian Clinical Advisory Board for Binge Eating Disorders. He has also been a recipient of travel grants, investigator-initiated research grants as well as commissioned reports. He is a member of the Commonwealth Government’s Technical Advisory Group on Eating Disorders and is an inaugural member of the National Eating Disorders Consortium. He receives royalties from Hogrefe and Huber, Taylor and Francis and McGraw Hill for published books/book chapters. He is conjoint Editor in Chief of the Journal of Eating Disorders.